| Case fatality rate of cancer patients with COVID-19 in a New York hospital system V Mehta, S Goel, R Kabarriti, D Cole, M Goldfinger, A Acuna-Villaorduna, ... Cancer discovery 10 (7), 935-941, 2020 | 793 | 2020 |
| PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab M Jhawer, S Goel, AJ Wilson, C Montagna, YH Ling, DS Byun, S Nasser, ... Cancer research 68 (6), 1953-1961, 2008 | 584 | 2008 |
| Novel patterns of response under immunotherapy E Borcoman, Y Kanjanapan, S Champiat, S Kato, V Servois, R Kurzrock, ... Annals of Oncology 30 (3), 385-396, 2019 | 434 | 2019 |
| Seroconversion rates following COVID-19 vaccination among patients with cancer A Thakkar, JD Gonzalez-Lugo, N Goradia, R Gali, LC Shapiro, K Pradhan, ... Cancer cell 39 (8), 1081-1090. e2, 2021 | 324 | 2021 |
| Patterns of response and progression to immunotherapy E Borcoman, A Nandikolla, G Long, S Goel, C Le Tourneau American Society of Clinical Oncology Educational Book 38, 169-178, 2018 | 242 | 2018 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies S Goel, AC Mita, M Mita, EK Rowinsky, QS Chu, N Wong, C Desjardins, ... Clinical Cancer Research 15 (12), 4207-4212, 2009 | 169 | 2009 |
| Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors R Gollamudi, MH Ghalib, KK Desai, I Chaudhary, B Wong, M Einstein, ... Investigational new drugs 28, 641-649, 2010 | 163 | 2010 |
| Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ... Cancer discovery 10 (10), 1514-1527, 2020 | 142 | 2020 |
| Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020; 10 (7): 935–941. doi: 10.1158/2159-8290 V Mehta, S Goel, R Kabarriti, D Cole, M Goldfinger, A Acuna-Villaorduna, ... CD-20-0516.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 142 | |
| PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild … A Sood, D McClain, R Maitra, A Basu-Mallick, R Seetharam, A Kaubisch, ... Clinical colorectal cancer 11 (2), 143-150, 2012 | 130 | 2012 |
| Flexural fatigue strength and failure probability of self compacting fibre reinforced concrete beams S Goel, SP Singh, P Singh Engineering Structures 40, 131-140, 2012 | 123 | 2012 |
| Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction AJ Wilson, AC Chueh, L Tögel, GA Corner, N Ahmed, S Goel, DS Byun, ... Cancer research 70 (2), 609-620, 2010 | 121 | 2010 |
| A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma D Mahalingam, S Goel, S Aparo, S Patel Arora, N Noronha, H Tran, ... Cancers 10 (6), 160, 2018 | 114 | 2018 |
| RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors H Cheng, Y Zou, JS Ross, K Wang, X Liu, B Halmos, SM Ali, H Liu, ... Cancer discovery 5 (12), 1262-1270, 2015 | 111 | 2015 |
| Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy A Thakkar, K Pradhan, S Jindal, Z Cui, B Rockwell, AP Shah, S Packer, ... Nature Cancer 2 (4), 392-399, 2021 | 106 | 2021 |
| CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer V Kumar, CS Yadav, S Singh, S Goel, RS Ahmed, S Gupta, RK Grover, ... Chemosphere 81 (4), 464-468, 2010 | 98 | 2010 |
| Eribulin—a review of preclinical and clinical studies U Swami, I Chaudhary, MH Ghalib, S Goel Critical reviews in oncology/hematology 81 (2), 163-184, 2012 | 96 | 2012 |
| Fatigue performance of plain and steel fibre reinforced self compacting concrete using S–N relationship S Goel, SP Singh Engineering Structures 74, 65-73, 2014 | 95 | 2014 |
| Phase I trial of a novel stapled peptide ALRN-6924 disrupting MDMX-and MDM2-mediated inhibition of WT p53 in patients with solid tumors and lymphomas F Meric-Bernstam, MN Saleh, JR Infante, S Goel, GS Falchook, G Shapiro, ... J Clin Oncol 35 (15_suppl), 2505, 2017 | 94 | 2017 |
